Status: current, Defined. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2116411000168113 | Bordetella pertussis filamentous haemagglutinin antigen 25 microgram + Bordetella pertussis toxoid 25 microgram + diphtheria toxoid 20 international units + Haemophilus influenzae serotype b conjugate (polyribosylribitol phosphate to tetanus toxoid) antigen 12 microgram + hepatitis B surface antigen 10 microgram + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units injection, 1 x 0.5 mL syringe (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2116421000168118 | diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2116511000168114 | diphtheria toxoid 20 units + tetanus toxoid 40 units + Bordetella pertussis toxoid 25 microgram + Bordetella pertussis filamentous haemagglutinin antigen 25 microgram + hepatitis B surface antigen 10 microgram + poliovirus type 1 inactivated antigen 40 D antigen units + poliovirus type 2 inactivated antigen 8 D antigen units + poliovirus type 3 inactivated antigen 32 D antigen units + Haemophilus influenzae type b conjugate (PRP-T) antigen 12 microgram, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2116521000168119 | DTPa-hepB-IPV-Hib (diphtheria + tetanus + pertussis + hepatitis B + inactivated poliomyelitis + Haemophilus influenzae type b conjugate (PRP-T)) vaccine, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe | Is a | polio trivalent inactivated vaccine injection, 0.5 mL syringe | true | Inferred relationship | Some | ||
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe | has MPUU | diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hexaxim injection, 0.5 mL syringe | Is a | True | diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product pack reference set
FHIR